Pacira BioSciences, Inc. (PCRX) Form 10-Q Quarterly Reports
Pacira BioSciences, Inc. (PCRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PCRX
CIK: 1396814
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJeffrey Knight
Audit LocationShort Hills, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-13 | — | SCHEDULE 13D/A Filing | 0001104659-26-115589 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-08 | FORM 4 | 0001628280-26-065566 | View SEC Doc Filr Page |
| SC TO-C | 2026-10-08 | — | SC TO-C | 0001140361-26-039148 | View SEC Doc Filr Page |
| SC14D9C | 2026-10-08 | — | SC14D9C | 0001104659-26-114706 | View SEC Doc Filr Page |
| 144 | 2026-10-08 | — | 144 Filing | 0001959173-26-007312 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-08 | FORM 8-K | 0001104659-26-114571 | View SEC Doc Filr Page |
| SC TO-C | 2026-10-08 | — | SC TO-C | 0001140361-26-039025 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001628280-26-057759 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001959173-26-006073 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000517 | View SEC Doc Filr Page |
| S-8 | 2026-08-04 | — | S-8 | 0001628280-26-052724 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q - PCRX - 06.30.2026 | 0001628280-26-052635 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001628280-26-052527 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-28 | 8-K | 0001628280-26-046136 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043010 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001628280-26-043009 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043008 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043007 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043006 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043005 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043004 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043003 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001628280-26-043002 | View SEC Doc Filr Page |
| 3 | 2026-06-12 | 2026-06-09 | FORM 3 | 0001628280-26-043001 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001959173-26-004600 | View SEC Doc Filr Page |